PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16842099-1	2006	Lead compounds directed to the 5" leader of the Amyloid Precursor Protein transcript (i.e., paroxetine (SSRI), N-acetyl cysteine (antioxidant), and erythromycin (macrolide antibiotic)) were employed in a pilot study to evaluate their anti-amyloid efficacy in the TgCRND8 transgenic mouse model for Alzheimer"s Disease (AD).	Paroxetine	92-102	amyloid beta (A4) precursor protein	Mus musculus	48-73	
16842099-2	2006	The relative levels of Abeta peptide were reduced after exposure of mice to paroxetine (N=5), NAC (N=7), and erythromycin (N=7) relative to matched placebo counterparts.	Paroxetine	76-86	amyloid beta (A4) precursor protein	Mus musculus	23-28	
16842099-3	2006	Paroxetine limited the levels of APP holoprotein and total Abeta peptide levels (measurements of Abeta were performed at two separate sites by quantitative western blotting and ELISA assay).	Paroxetine	0-10	amyloid beta (A4) precursor protein	Mus musculus	59-64	
15974925-4	2005	The relative levels of Abeta peptide levels were reduced after exposure of mice to paroxetine (N=5), NAC (N=7), and erythromycin (N=7) relative to matched placebo counterparts.	Paroxetine	83-93	amyloid beta (A4) precursor protein	Mus musculus	23-28	
17368447-7	2007	Levels of amyloid beta-peptide (Abeta) and numbers of Abeta immunoreactive neurons were significantly reduced in the hippocampus of male and female paroxetine-treated 3xTgAD mice compared to saline-treated 3xTgAD mice.	Paroxetine	148-158	amyloid beta (A4) precursor protein	Mus musculus	32-37	
17368447-7	2007	Levels of amyloid beta-peptide (Abeta) and numbers of Abeta immunoreactive neurons were significantly reduced in the hippocampus of male and female paroxetine-treated 3xTgAD mice compared to saline-treated 3xTgAD mice.	Paroxetine	148-158	amyloid beta (A4) precursor protein	Mus musculus	54-59